Are Under the Muscle Breast Implants Better? What Surgeons Weigh

Yes, in most cases, under the muscle breast implants are better for first-time cosmetic augmentation in women with thin tissue coverage. Placement beneath the pectoralis major muscle lowers the visible rippling rate, improves upper-pole softness, and reduces the chance of visible implant edges. The trade-off is a longer recovery, temporary animation deformity when the chest muscle contracts, and higher surgical complexity. The "better" answer flips for tuberous breasts, significant sagging requiring a lift, and some revision cases. Placement is not a universal rule; it is a tissue-by-tissue calculation.

What "Under the Muscle" Actually Means

The phrase covers multiple anatomical planes that surgeons often blur together. The classic dual-plane technique places the upper two-thirds of the implant behind the pectoralis major muscle while the lower third sits under the gland and fascia. This split is now the most common approach in the United States, and it is what most people mean when they say "under the muscle."

Full submuscular placement sits entirely behind the muscle. This is more common in reconstruction after mastectomy than in cosmetic augmentation. Subfascial placement rests on top of the muscle but beneath its thin fascial covering. It is technically not "under the muscle," though it appears in the same family of deeper placements.

The mechanism matters for why outcomes differ. The pectoralis muscle provides an extra layer of soft-tissue padding over the upper half of the implant. That padding covers the thinnest part of the chest wall, which is where rippling and edge visibility most often appear. The muscle also holds the implant in a more oval shape at the upper pole and dampens the pull of gravity over time.

In plain terms: the muscle acts as a living blanket over the part of the implant most likely to show its edges.

Why Muscle Coverage Changes Outcomes

Three mechanisms drive most of the clinical difference between under and over placement. Each has a measurable signature.

The first is soft-tissue camouflage. The upper chest in many women has less than 2 cm of subcutaneous fat. When implant volume presses against skin with thin coverage, the implant's fill pattern, folds, and shell texture can show through. Muscle adds roughly 5 to 10 mm of additional thickness over that zone, according to cadaveric and MRI-based measurements. That extra millimeter count is what pushes visible rippling rates down.

The second is implant support. The pectoralis attaches to the sternum, clavicle, and humerus, creating a sling that bears some of the implant's weight. Over a decade, an unsupported implant pulls the lower pole downward. Under the muscle, the sling reduces that creep, which is one reason long-term ptosis rates are lower in submuscular cohorts.

The third is capsular dynamics. The capsule forms around whatever surface the implant contacts. A submuscular capsule sits against muscle that moves with every arm raise and hug. The movement is thought to distribute mechanical stress across the capsule more evenly, which some surgeons link to lower rates of severe capsular contracture. That link remains debated; the mechanism is plausible but not settled.

One non-obvious detail: the muscle does not cover the entire implant. Only the upper portion is protected. The lower pole still rests against gland and skin. So "under the muscle" is a partial coat, not a full wrapper, and that distinction explains why rippling sometimes still appears at the bottom edge.

Quantified Comparison: Under vs Over the Muscle

The table below reconciles published ranges across the two placements. Values are typical estimates, not guarantees, and individual anatomy shifts every number.

The rippling and contracture figures are the ones most cited in favor of submuscular placement. The animation deformity figure is the counterweight that rarely gets equal airtime. In a 2021 study of 340 patients by a European plastic surgery group, roughly one in six dual-plane patients reported visible chest distortion when flexing, and 4% considered it severe enough to want revision.

That is the buried trade-off. Under the muscle wins on concealment and support, then loses on motion cosmetics. Patients who lift weights, dance, or perform in front of cameras should weigh animation deformity heavily.

When Over the Muscle Wins

Over placement is not obsolete. Four scenarios favor it.

Patients with tuberous breasts or constricted lower poles often do better with over placement combined with a release. The muscle can constrain the lower-pole expansion the implant needs to reshape a constricted base.

Patients needing a simultaneous lift with large implants may get better lower-pole projection from subglandular placement. The muscle holds the implant too high in some of these cases.

Patients with very active upper bodies, especially competitive lifters, frequently dislike the animation deformity more than they dislike rippling. Over placement removes that motion artifact entirely.

Revision patients seeking correction of symmastia or a wide cleavage may benefit from over placement, because the muscle cannot be stretched beyond its sternal attachment without tearing.

The Animation Deformity Problem

Animation deformity is the technical name for an implant that visibly moves when the chest muscle contracts. The implant sits beneath the pectoralis, so every contraction presses the implant outward and pulls the overlying gland. The result is a bulge, a valley, or a lateral swing depending on the implant's position and the patient's muscle bulk.

Rates range from 10% to 25% in clinical series depending on how the survey question is asked. Subjective mild movement is far more common than bothersome deformity. In one series of 200 patients, 22% noticed movement, but only 3% rated it unacceptable.

The fix is usually not removal. Injecting fat over the upper pole, switching to a smaller implant, or converting to a partial subfascial pocket can reduce it. Full conversion to prepectoral placement requires a capsule change and is a bigger operation.

One professional caveat: animation deformity is underreported in surgeon-authored reviews, because it rarely prompts a formal revision. Anchor studies that measure it directly, not those that rely on chart review, give the higher figures.

Recovery Timeline and Motion Milestones

Timing differs meaningfully by placement. The table below reflects typical bilateral cosmetic augmentation with 300 to 400 cc implants.

The "drop and fluff" phenomenon is the implant settling into the lower pole over 3 to 6 months. Under the muscle, this process can take 2 to 4 weeks longer because the muscle must relax around the implant. Patients should not judge the final result before month six.

The single most important recovery instruction is arm restriction. Raising the arm above shoulder height in the first two weeks risks displacing an under-the-muscle implant upward. That advice has a hard cutoff: most surgeons lift it between week two and week four, and full chest work returns around week six to eight.

Common Misconceptions Corrected

Several myths persist because they were true for older implant generations.

Myth one: under the muscle always looks more natural. It usually does, but a thin patient over the muscle with a cohesive silicone implant can look excellent, and an animate, muscular patient under the muscle can look worse than the alternative.

Myth two: over the muscle has a much higher rupture rate. There is no consistent, high-quality evidence for a rupture difference by plane. Rupture rates track implant generation and shell design more than placement.

Myth three: under the muscle prevents the need for future lift. It does not. Pregnancy, weight change, and age still stretch the skin envelope, and many women need a mastopexy regardless of plane.

Myth four: subglandular placement is outdated. It remains standard for specific indications and is preferred by some high-volume surgeons in Europe.

A subtler misconception: patients often believe "under the muscle" means fully behind the muscle. Dual-plane placement is partial. That distinction changes how much rippling protection the muscle actually provides.

What to Actually Do Before Choosing

The decision should follow a short sequence, not a generic preference.

First, ask for tissue pinch measurements at the upper pole and lower pole. A pinch under 2 cm at the upper chest favors submuscular coverage. Above 3 cm, the argument for muscle coverage weakens.

Second, identify animation risk. Anyone who lifts heavy weights, swims competitively, or appears on camera regularly should test their tolerance by flexing in front of a mirror and picturing the implant moving with each contraction.

Third, confirm the plan for the lower pole. If a lift is needed, the combined operation changes which plane makes sense.

Fourth, ask specifically whether the surgeon plans dual-plane, full submuscular, or subfascial. The words matter, and the answer should be in the operative plan.

Fifth, review implant profile and volume together with the plane. A high-profile implant in a thin patient often benefits most from muscle coverage.

Red flags in a consultation:

• A surgeon offers one plane for every patient without measuring tissue thickness.
• No discussion of animation deformity.
• No mention of mammography screening and how the plane affects imaging.
• Promises of "lifetime" implants or guarantees against contracture.
• Pressure to decide without a second opinion.

Limitations and What the Evidence Cannot Settle

Plane choice is a surgical judgment, not a single trial-determined answer. No large randomized controlled trial has directly compared submuscular and subglandular placement in cosmetic augmentation. Most comparative evidence comes from observational cohorts, and those cohorts vary in implant generation, surgeon skill, and follow-up length.

The capsular contracture gap is the most contested number. Some reviews find a modest difference favoring submuscular placement; others find none after controlling for implant surface and texturing. The 2019 FDA silicone implant labeling update did not establish a plane-specific risk figure, and regulators have repeatedly noted that long-term data remain incomplete.

There is also a shifting context. The 2023 recall wave affecting certain macrotextured implants changed practice patterns globally, and plane choice is now increasingly evaluated alongside implant surface, not on its own.

What the evidence does support with reasonable confidence: submuscular placement reduces visible rippling, improves upper-pole softness, and may reduce severe contracture. What it does not support: a universal rule, a guarantee of a better look, or a fixed advantage across all anatomies.

A reasonable final statement is that under the muscle is better for most first-time cosmetic patients with thin coverage, better for implant support over decades, and worse for motion cosmetics and recovery speed. Patients with thick tissue, heavy athletic demands, or specific anatomical constraints should expect the recommendation to flip.